{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:07:36Z","timestamp":1791587256251,"version":"4.3.4"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Associazione Angelman"},{"name":"FROM"},{"DOI":"10.13039\/100007013","name":"F. Hoffmann-La Roche Ltd.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007013","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100001951","name":"Angelman Syndrome Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100001951","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Molecular Autism"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Angelman Syndrome (AS) is a severe neurodevelopmental disorder with only symptomatic treatment currently available. The primary cause of AS is loss of functional UBE3A protein. This can be caused by deletions in the maternal 15q11-q13 region, maternal AS-imprinting center defects (mICD), paternal uniparental disomy of chromosome 15 (UPD) or mutations within the <jats:italic>UBE3A<\/jats:italic> gene. Current mouse models are <jats:italic>Ube3a<\/jats:italic>-centric and do not address expression changes of other genes in the 15q11-q13 locus on the pathophysiology of AS. This limits the ability to discern differences in therapeutic responses to current UBE3A-targeting strategies and hampers the identification of novel therapeutics\/co-therapeutics.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Using a mouse line that harbors a maternally inherited mutation affecting the AS-PWS imprinting center (\u2018mICD mice\u2019), we studied the impact of the mICD or UPD AS subtype on behavior, seizure susceptibility and proteome. Additionally, by using mice overexpressing two copies of <jats:italic>Ube3a<\/jats:italic> or antisense oligonucleotide (ASO) targeting <jats:italic>Ube3a-ATS<\/jats:italic>, we analyzed the impact of bi-allelic <jats:italic>Ube3a<\/jats:italic> activation on behavior and proteome.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>mICD mice showed 80% reduction in UBE3A protein, bi-allelic expression of <jats:italic>Ube3a-ATS<\/jats:italic> and <jats:italic>Mkrn3-Snord115<\/jats:italic> gene cluster, leading to robust AS behavioral deficits and proteome alterations similar to <jats:italic>Ube3a<\/jats:italic>\n              <jats:sup>\n                <jats:italic>m\u2212\/p+<\/jats:italic>\n              <\/jats:sup> mice. Genetic UBE3A overexpression in mICD mice, mimicking therapeutic strategies that effectively activate the biallelic silenced <jats:italic>Ube3a<\/jats:italic> gene, resulted in a complete rescue of all behavioral phenotypes, seizure susceptibility and proteome alterations. Subsequently, treatment with an antisense oligonucleotide (ASO) to directly activate the biallelic silenced <jats:italic>Ube3a<\/jats:italic> gene in mICD mice also resulted in efficient reinstatement of UBE3A, 30% higher relative to WT, alongside a partial rescue of behavioral phenotypes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Limitations<\/jats:title>\n            <jats:p>Despite using a highly robust AS-specific behavioral battery, we did not investigate readouts such as neuronal activity and sleep, for which impairments in <jats:italic>Ube3a<\/jats:italic>\n              <jats:sup>\n                <jats:italic>m\u2212\/p+<\/jats:italic>\n              <\/jats:sup> mice were described.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Taken together, these findings demonstrate that the loss of UBE3A protein is the primary factor underlying AS phenotypes in this mICD\/UPD mouse model of AS, while the biallelic expressed genes in this locus play either a marginal or yet unidentified role. These findings also corroborate UBE3A reinstatement as an attractive therapeutic strategy for AS individuals carrying an mICD or UPD mutation.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13229-025-00675-z","type":"journal-article","created":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T15:46:28Z","timestamp":1756395988000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["UBE3A reinstatement restores behaviorand proteome in an Angelman syndrome mouse model of imprinting defects"],"prefix":"10.1186","volume":"16","author":[{"given":"Claudia","family":"Milazzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4456-5241","authenticated-orcid":false,"given":"Ramanathan","family":"Narayanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solveig","family":"Badillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosaisela","family":"Almand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roos","family":"Monshouwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Tzouros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Golling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6700-9259","authenticated-orcid":false,"given":"Edwin","family":"Mientjes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4720-9680","authenticated-orcid":false,"given":"Stormy","family":"Chamberlain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kremer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3758-1297","authenticated-orcid":false,"given":"Ype","family":"Elgersma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,28]]},"reference":[{"issue":"9","key":"675_CR1","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1002\/ajmg.a.36058","volume":"161A","author":"LG Mertz","year":"2013","unstructured":"Mertz LG, Christensen R, Vogel I, Hertz JM, Nielsen KB, Gronskov K, et al. Angelman syndrome in denmark. Birth incidence, genetic findings, and age at diagnosis. Am J Med Genet A. 2013;161A(9):2197\u2013203.","journal-title":"Am J Med Genet A"},{"issue":"5","key":"675_CR2","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1002\/ajmg.a.31074","volume":"140","author":"CA Williams","year":"2006","unstructured":"Williams CA, Beaudet AL, Clayton-Smith J, Knoll JH, Kyllerman M, Laan LA, et al. Angelman syndrome 2005: updated consensus for diagnostic criteria. Am J Med Genet A. 2006;140(5):413\u20138.","journal-title":"Am J Med Genet A"},{"issue":"1","key":"675_CR3","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/ajmg.a.61382","volume":"182","author":"K Bindels-de Heus","year":"2020","unstructured":"Bindels-de Heus K, Mous SE, Ten Hooven-Radstaake M, van Iperen-Kolk BM, Navis C, Rietman AB, et al. An overview of health issues and development in a large clinical cohort of children with Angelman syndrome. Am J Med Genet A. 2020;182(1):53\u201363.","journal-title":"Am J Med Genet A"},{"issue":"10","key":"675_CR4","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/nrneurol.2016.133","volume":"12","author":"K Buiting","year":"2016","unstructured":"Buiting K, Williams C, Horsthemke B. Angelman syndrome - insights into a rare neurogenetic disorder. Nat Rev Neurol. 2016;12(10):584\u201393.","journal-title":"Nat Rev Neurol"},{"issue":"7","key":"675_CR5","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.2217\/epi.15.70","volume":"7","author":"JM LaSalle","year":"2015","unstructured":"LaSalle JM, Reiter LT, Chamberlain SJ. Epigenetic regulation of UBE3A and roles in human neurodevelopmental disorders. Epigenomics. 2015;7(7):1213\u201328.","journal-title":"Epigenomics"},{"key":"675_CR6","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.neuroscience.2020.02.017","volume":"445","author":"DC Rotaru","year":"2020","unstructured":"Rotaru DC, Mientjes EJ, Elgersma Y. Angelman syndrome: from mouse models to therapy. Neuroscience. 2020;445:172\u201389.","journal-title":"Neuroscience"},{"issue":"2","key":"675_CR7","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1007\/s10803-020-04861-1","volume":"53","author":"A Sadhwani","year":"2023","unstructured":"Sadhwani A, Wheeler A, Gwaltney A, Peters SU, Barbieri-Welge RL, Horowitz LT, et al. Developmental skills of individuals with Angelman syndrome assessed using the Bayley-III. J Autism Dev Disord. 2023;53(2):720\u201337.","journal-title":"J Autism Dev Disord"},{"key":"675_CR8","doi-asserted-by":"crossref","unstructured":"Judson MC, Shyng C, Simon JM, Davis CR, Punt AM, Salmon MT et al. Dual-isoform hUBE3A gene transfer improves behavioral and seizure outcomes in Angelman syndrome model mice. JCI Insight. 2021;6(20).","DOI":"10.1172\/jci.insight.144712"},{"issue":"7539","key":"675_CR9","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/nature13975","volume":"518","author":"L Meng","year":"2015","unstructured":"Meng L, Ward AJ, Chun S, Bennett CF, Beaudet AL, Rigo F. Towards a therapy for Angelman syndrome by targeting a long non-coding RNA. Nature. 2015;518(7539):409\u201312.","journal-title":"Nature"},{"key":"675_CR10","doi-asserted-by":"crossref","unstructured":"Milazzo C, Mientjes EJ, Wallaard I, Rasmussen SV, Erichsen KD, Kakunuri T et al. Antisense oligonucleotide treatment rescues UBE3A expression and multiple phenotypes of an Angelman syndrome mouse model. JCI Insight. 2021;6(15).","DOI":"10.1172\/jci.insight.145991"},{"issue":"7833","key":"675_CR11","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/s41586-020-2835-2","volume":"587","author":"JM Wolter","year":"2020","unstructured":"Wolter JM, Mao H, Fragola G, Simon JM, Krantz JL, Bazick HO, et al. Cas9 gene therapy for Angelman syndrome traps Ube3a-ATS long non-coding RNA. Nature. 2020;587(7833):281\u20134.","journal-title":"Nature"},{"issue":"6","key":"675_CR12","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.tins.2011.04.001","volume":"34","author":"AM Mabb","year":"2011","unstructured":"Mabb AM, Judson MC, Zylka MJ, Philpot BD. Angelman syndrome: insights into genomic imprinting and neurodevelopmental phenotypes. Trends Neurosci. 2011;34(6):293\u2013303.","journal-title":"Trends Neurosci"},{"issue":"13","key":"675_CR13","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.1093\/hmg\/dds130","volume":"21","author":"L Meng","year":"2012","unstructured":"Meng L, Person RE, Beaudet AL. Ube3a-ATS is an atypical RNA polymerase II transcript that represses the paternal expression of Ube3a. Hum Mol Genet. 2012;21(13):3001\u201312.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"675_CR14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/ng0598-15","volume":"19","author":"C Rougeulle","year":"1998","unstructured":"Rougeulle C, Cardoso C, Fontes M, Colleaux L, Lalande M. An imprinted antisense RNA overlaps UBE3A and a second maternally expressed transcript. Nat Genet. 1998;19(1):15\u20136.","journal-title":"Nat Genet"},{"issue":"23","key":"675_CR15","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1093\/hmg\/10.23.2687","volume":"10","author":"M Runte","year":"2001","unstructured":"Runte M, Huttenhofer A, Gross S, Kiefmann M, Horsthemke B, Buiting K. The IC-SNURF-SNRPN transcript serves as a host for multiple small nucleolar RNA species and as an antisense RNA for UBE3A. Hum Mol Genet. 2001;10(23):2687\u2013700.","journal-title":"Hum Mol Genet"},{"issue":"41","key":"675_CR16","doi-asserted-by":"publisher","first-page":"17668","DOI":"10.1073\/pnas.1004487107","volume":"107","author":"SJ Chamberlain","year":"2010","unstructured":"Chamberlain SJ, Chen PF, Ng KY, Bourgois-Rocha F, Lemtiri-Chlieh F, Levine ES, et al. Induced pluripotent stem cell models of the genomic imprinting disorders Angelman and Prader-Willi syndromes. Proc Natl Acad Sci U S A. 2010;107(41):17668\u201373.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7571","key":"675_CR17","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/526050b","volume":"526","author":"Y Elgersma","year":"2015","unstructured":"Elgersma Y. Neurodevelopmental disease: A molecular tightrope. Nature. 2015;526(7571):50\u20131.","journal-title":"Nature"},{"key":"675_CR18","doi-asserted-by":"crossref","unstructured":"Punt AM, Judson MC, Sidorov MS, Williams BN, Johnson NS, Belder S et al. Molecular and behavioral consequences of Ube3a gene overdosage in mice. JCI Insight. 2022;7(18).","DOI":"10.1172\/jci.insight.158953"},{"issue":"2","key":"675_CR19","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1093\/hmg\/ddy345","volume":"28","author":"MW Lewis","year":"2019","unstructured":"Lewis MW, Vargas-Franco D, Morse DA, Resnick JL. A mouse model of Angelman syndrome imprinting defects. Hum Mol Genet. 2019;28(2):220\u20139.","journal-title":"Hum Mol Genet"},{"key":"675_CR20","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13229-018-0231-7","volume":"9","author":"M Sonzogni","year":"2018","unstructured":"Sonzogni M, Wallaard I, Santos SS, Kingma J, du Mee D, van Woerden GM, et al. A behavioral test battery for mouse models of Angelman syndrome: a powerful tool for testing drugs and novel Ube3a mutants. Mol Autism. 2018;9:47.","journal-title":"Mol Autism"},{"issue":"31","key":"675_CR21","doi-asserted-by":"publisher","first-page":"7347","DOI":"10.1523\/JNEUROSCI.0037-17.2017","volume":"37","author":"MC Judson","year":"2017","unstructured":"Judson MC, Burette AC, Thaxton CL, Pribisko AL, Shen MD, Rumple AM, et al. Decreased axon caliber underlies loss of fiber tract integrity, disproportional reductions in white matter volume, and microcephaly in Angelman syndrome model mice. J Neurosci. 2017;37(31):7347\u201361.","journal-title":"J Neurosci"},{"issue":"3","key":"675_CR22","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1210\/me.2005-0110","volume":"20","author":"OY Khan","year":"2006","unstructured":"Khan OY, Fu G, Ismail A, Srinivasan S, Cao X, Tu Y, et al. Multifunction steroid receptor coactivator, E6-associated protein, is involved in development of the prostate gland. Mol Endocrinol. 2006;20(3):544\u201359.","journal-title":"Mol Endocrinol"},{"issue":"2","key":"675_CR23","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1128\/MCB.19.2.1182","volume":"19","author":"Z Nawaz","year":"1999","unstructured":"Nawaz Z, Lonard DM, Smith CL, Lev-Lehman E, Tsai SY, Tsai MJ, et al. The Angelman syndrome-associated protein, E6-AP, is a coactivator for the nuclear hormone receptor superfamily. Mol Cell Biol. 1999;19(2):1182\u20139.","journal-title":"Mol Cell Biol"},{"key":"675_CR24","doi-asserted-by":"publisher","first-page":"e006","DOI":"10.1621\/nrs.06006","volume":"6","author":"S Ramamoorthy","year":"2008","unstructured":"Ramamoorthy S, Nawaz Z. E6-associated protein (E6-AP) is a dual function coactivator of steroid hormone receptors. Nucl Recept Signal. 2008;6:e006.","journal-title":"Nucl Recept Signal"},{"key":"675_CR25","doi-asserted-by":"crossref","unstructured":"Viho EMG, Punt AM, Distel B, Houtman R, Kroon J, Elgersma Y et al. The hippocampal response to acute corticosterone elevation is altered in a mouse model for Angelman syndrome. Int J Mol Sci. 2022;24(1).","DOI":"10.3390\/ijms24010303"},{"issue":"5","key":"675_CR26","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1038\/s41380-022-01484-z","volume":"27","author":"NJ Pandya","year":"2022","unstructured":"Pandya NJ, Meier S, Tyanova S, Terrigno M, Wang C, Punt AM, et al. A cross-species Spatiotemporal proteomic analysis identifies UBE3A-dependent signaling pathways and targets. Mol Psychiatry. 2022;27(5):2590\u2013601.","journal-title":"Mol Psychiatry"},{"issue":"3","key":"675_CR27","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1089\/nat.2021.0071","volume":"32","author":"PH Hagedorn","year":"2022","unstructured":"Hagedorn PH, Brown JM, Easton A, Pierdomenico M, Jones K, Olson RE, et al. Acute neurotoxicity of antisense oligonucleotides after intracerebroventricular injection into mouse brain can be predicted from sequence features. Nucleic Acid Ther. 2022;32(3):151\u201362.","journal-title":"Nucleic Acid Ther"},{"key":"675_CR28","doi-asserted-by":"crossref","unstructured":"Hoyos Sanchez MC, Bayat T, Gee RRF, Fon Tacer K. Hormonal imbalances in Prader-Willi and Schaaf-Yang syndromes imply the evolution of specific regulation of hypothalamic neuroendocrine function in mammals. Int J Mol Sci. 2023;24(17).","DOI":"10.3390\/ijms241713109"},{"issue":"20","key":"675_CR29","doi-asserted-by":"publisher","first-page":"5383","DOI":"10.1523\/JNEUROSCI.1262-06.2006","volume":"26","author":"T Kuwajima","year":"2006","unstructured":"Kuwajima T, Nishimura I, Yoshikawa K. Necdin promotes GABAergic neuron differentiation in Cooperation with Dlx homeodomain proteins. J Neurosci. 2006;26(20):5383\u201392.","journal-title":"J Neurosci"},{"issue":"7","key":"675_CR30","doi-asserted-by":"publisher","first-page":"3796","DOI":"10.1093\/nar\/gkab155","volume":"49","author":"C Li","year":"2021","unstructured":"Li C, Han T, Li Q, Zhang M, Guo R, Yang Y, et al. MKRN3-mediated ubiquitination of Poly(A)-binding proteins modulates the stability and translation of GNRH1 mRNA in mammalian puberty. Nucleic Acids Res. 2021;49(7):3796\u2013813.","journal-title":"Nucleic Acids Res"},{"issue":"14","key":"675_CR31","doi-asserted-by":"publisher","first-page":"7944","DOI":"10.1093\/nar\/gkaa601","volume":"48","author":"R Lu","year":"2020","unstructured":"Lu R, Dong Y, Li JD. Necdin regulates BMAL1 stability and circadian clock through SGT1-HSP90 chaperone machinery. Nucleic Acids Res. 2020;48(14):7944\u201357.","journal-title":"Nucleic Acids Res"},{"key":"675_CR32","doi-asserted-by":"crossref","unstructured":"Born HA, Dao AT, Levine AT, Lee WL, Mehta NM, Mehra S. Strain-dependence of the Angelman syndrome phenotypes in Ube3a maternal deficiency mice. Sci Rep. 2017;7(1).","DOI":"10.1038\/s41598-017-08825-x"},{"issue":"4","key":"675_CR33","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/S0896-6273(00)80596-6","volume":"21","author":"Y Jiang","year":"1998","unstructured":"Jiang Y, hui, Armstrong D, Albrecht U, Atkins CM, Noebels JL, Eichele G, et al. Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation. Neuron. 1998;21(4):799\u2013811.","journal-title":"Neuron"},{"issue":"5","key":"675_CR34","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1172\/JCI80554","volume":"125","author":"S Silva-Santos","year":"2015","unstructured":"Silva-Santos S, van Woerden GM, Bruinsma CF, Mientjes E, Jolfaei MA, Distel B, et al. Ube3a reinstatement identifies distinct developmental windows in a murine Angelman syndrome model. J Clin Invest. 2015;125(5):2069\u201376.","journal-title":"J Clin Invest"},{"key":"675_CR35","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3389\/fnins.2016.00033","volume":"10","author":"JW Zhu","year":"2016","unstructured":"Zhu JW, Li YF, Wang ZT, Jia WQ, Xu RX. Toll-Like receptor 4 deficiency impairs motor coordination. Front Neurosci. 2016;10:33.","journal-title":"Front Neurosci"},{"issue":"1","key":"675_CR36","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29(1):15\u201321.","journal-title":"Bioinformatics"},{"issue":"19","key":"675_CR37","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1093\/bioinformatics\/btw354","volume":"32","author":"P Ewels","year":"2016","unstructured":"Ewels P, Magnusson M, Lundin S, Kaller M. MultiQC: summarize analysis results for multiple tools and samples in a single report. Bioinformatics. 2016;32(19):3047\u20138.","journal-title":"Bioinformatics"},{"issue":"7","key":"675_CR38","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao Y, Smyth GK, Shi W. FeatureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014;30(7):923\u201330.","journal-title":"Bioinformatics"},{"issue":"1","key":"675_CR39","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson MD, McCarthy DJ, Smyth GK. EdgeR: a bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26(1):139\u201340.","journal-title":"Bioinformatics"},{"issue":"5","key":"675_CR40","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1074\/mcp.M114.044305","volume":"14","author":"R Bruderer","year":"2015","unstructured":"Bruderer R, Bernhardt OM, Gandhi T, Miladinovic SM, Cheng LY, Messner S, et al. Extending the limits of quantitative proteome profiling with data-independent acquisition and application to acetaminophen-treated three-dimensional liver microtissues. Mol Cell Proteom. 2015;14(5):1400\u201310.","journal-title":"Mol Cell Proteom"},{"issue":"7","key":"675_CR41","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1021\/acs.jproteome.2c00122","volume":"21","author":"M Tognetti","year":"2022","unstructured":"Tognetti M, Sklodowski K, Muller S, Kamber D, Muntel J, Bruderer R, et al. Biomarker candidates for tumors identified from Deep-Profiled plasma stem predominantly from the low abundant area. J Proteome Res. 2022;21(7):1718\u201335.","journal-title":"J Proteome Res"},{"issue":"D1","key":"675_CR42","doi-asserted-by":"publisher","first-page":"D506","DOI":"10.1093\/nar\/gky1049","volume":"47","author":"UniProt C","year":"2019","unstructured":"UniProt C. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res. 2019;47(D1):D506\u201315.","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"675_CR43","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"675_CR44","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1214\/16-AOAS920","volume":"10","author":"B Phipson","year":"2016","unstructured":"Phipson B, Lee S, Majewski IJ, Alexander WS, Smyth GK. Robust hyperparameter Estimation protects against hypervariable genes and improves power to detect differential expression. Ann Appl Stat. 2016;10(2):946\u201363.","journal-title":"Ann Appl Stat"},{"key":"675_CR45","unstructured":"Gene Ontology C, Aleksander SA, Balhoff J, Carbon S, Cherry JM, Drabkin HJ et al. The gene ontology knowledgebase in 2023. Genetics. 2023;224(1)."},{"issue":"17","key":"675_CR46","doi-asserted-by":"publisher","first-page":"e133","DOI":"10.1093\/nar\/gks461","volume":"40","author":"D Wu","year":"2012","unstructured":"Wu D, Smyth GK. Camera: a competitive gene set test accounting for inter-gene correlation. Nucleic Acids Res. 2012;40(17):e133.","journal-title":"Nucleic Acids Res"},{"issue":"43","key":"675_CR47","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545\u201350.","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Molecular Autism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13229-025-00675-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13229-025-00675-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13229-025-00675-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T05:08:27Z","timestamp":1757480907000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularautism.biomedcentral.com\/articles\/10.1186\/s13229-025-00675-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,28]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["675"],"URL":"https:\/\/doi.org\/10.1186\/s13229-025-00675-z","relation":{},"ISSN":["2040-2392"],"issn-type":[{"value":"2040-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,28]]},"assertion":[{"value":"19 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were conducted in accordance with the European Commission Council Directive 2010\/63\/EU (CCD license AVD101002016791 and AVD10100202216352).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have approved the final manuscript and consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"45"}}